CymaBay Therapeutics Inc. (CBAY)
NASDAQ: CBAY · Delayed Price · USD
1.97
0.05 (2.60%)
At close: May 26, 2022 4:00 PM
2.06
0.09 (4.57%)
After-hours:May 26, 2022 5:17 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 10 | 0 | 0 | 0 | 0 | 3.05 | Upgrade |
| Gross Profit | 0 | 0 | 0 | 0 | 10 | 0 | 0 | 0 | 0 | 3.05 | Upgrade |
| Selling, General & Admin | 23.04 | 16.72 | 19.24 | 14.38 | 12.39 | 9.65 | 8.87 | 8.19 | 4.87 | 4.21 | Upgrade |
| Research & Development | 64.54 | 35.88 | 83.84 | 58.12 | 18.94 | 15.94 | 17.03 | 15.82 | 4.53 | 9.28 | Upgrade |
| Other Operating Expenses | 0 | 0 | 5.08 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade |
| Operating Expenses | 87.58 | 52.6 | 108.15 | 72.51 | 31.33 | 25.59 | 25.9 | 24.01 | 9.4 | 13.49 | Upgrade |
| Operating Income | -87.58 | -52.6 | -108.15 | -72.51 | -21.33 | -25.59 | -25.9 | -24.01 | -9.4 | -10.44 | Upgrade |
| Interest Expense / Income | 2.58 | 0 | 0 | 0.34 | 1.08 | 1.34 | 0.91 | 0.76 | 0.82 | 0.84 | Upgrade |
| Other Expense / Income | -0.17 | -1.62 | -5.34 | -0.29 | 5.15 | -0.25 | -11.28 | 7.15 | -254.21 | 12.62 | Upgrade |
| Pretax Income | -90 | -50.99 | -102.81 | -72.55 | -27.56 | -26.67 | -15.53 | -31.92 | 243.99 | -23.9 | Upgrade |
| Net Income | -90 | -50.99 | -102.81 | -72.55 | -27.56 | -26.67 | -15.53 | -31.92 | 243.99 | -23.9 | Upgrade |
| Net Income Common | -90 | -50.99 | -102.81 | -72.55 | -27.56 | -26.67 | -15.53 | -31.92 | 243.99 | -23.9 | Upgrade |
| Shares Outstanding (Basic) | 71 | 69 | 67 | 58 | 35 | 23 | 19 | 12 | 2 | 0 | Upgrade |
| Shares Outstanding (Diluted) | 71 | 69 | 67 | 58 | 35 | 23 | 19 | 12 | 3 | 0 | Upgrade |
| Shares Change | 3.14% | 2.77% | 15.90% | 65.71% | 48.86% | 23.95% | 57.00% | 323.42% | 49063.94% | - | Upgrade |
| EPS (Basic) | -1.27 | -0.74 | -1.53 | -1.25 | -0.79 | -1.14 | -0.82 | -2.65 | 103.52 | -4.00 | Upgrade |
| EPS (Diluted) | -1.27 | -0.74 | -1.53 | -1.26 | -0.79 | -1.14 | -0.83 | -2.65 | -3.54 | -4.00 | Upgrade |
| Free Cash Flow Per Share | -0.98 | -0.65 | -1.47 | -0.96 | -0.56 | -1.00 | -1.23 | -1.76 | -3.31 | -1.00 | Upgrade |
| Gross Margin | - | - | - | - | 100.00% | - | - | - | - | 100.00% | Upgrade |
| Operating Margin | - | - | - | - | -213.25% | - | - | - | - | -342.23% | Upgrade |
| Profit Margin | - | - | - | - | -275.57% | - | - | - | - | -783.57% | Upgrade |
| Free Cash Flow Margin | - | - | - | - | -196.59% | - | - | - | - | -370.26% | Upgrade |
| EBITDA | -86.73 | -50.35 | -102.24 | -72.11 | -26.44 | -25.31 | -14.59 | -31.14 | 244.87 | -22.94 | Upgrade |
| EBITDA Margin | - | - | - | - | -264.42% | - | - | - | - | -752.10% | Upgrade |
| EBIT | -87.42 | -50.99 | -102.81 | -72.21 | -26.48 | -25.33 | -14.62 | -31.16 | 244.82 | -23.06 | Upgrade |
| EBIT Margin | - | - | - | - | -264.77% | - | - | - | - | -756.00% | Upgrade |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).